Home › Compare › SAVAW vs O

SAVAW vs O: Dividend Comparison 2026

SAVAW yields 6666.67% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SAVAW wins by $1028095347812062.00M in total portfolio value
10 years
SAVAW
SAVAW
● Live price
6666.67%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1028095347812062.00M
Annual income
$998,628,545,336,266,700,000.00
Full SAVAW calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — SAVAW vs O

📍 SAVAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAVAWO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAVAW + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SAVAW pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAVAW
Annual income on $10K today (after 15% tax)
$566,666.67/yr
After 10yr DRIP, annual income (after tax)
$848,834,263,535,826,600,000.00/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, SAVAW beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAVAW + O for your $10,000?

SAVAW: 50%O: 50%
100% O50/50100% SAVAW
Portfolio after 10yr
$514047673906031.00M
Annual income
$499,314,272,668,133,360,000.00/yr
Blended yield
97.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

SAVAW
No analyst data
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAVAW buys
0
O buys
0
No recent congressional trades found for SAVAW or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAVAWO
Forward yield6666.67% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$1028095347812062.00M ✓$34.2K
Annual income after 10y$998,628,545,336,266,700,000.00 ✓$5,098.20
Total dividends collected$1026118102492338.88M ✓$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: SAVAW vs O ($10,000, DRIP)

YearSAVAW PortfolioSAVAW Income/yrO PortfolioO Income/yrGap
1← crossover$677,367$666,666.67$10,818$607.86+$666.5K → SAVAW
2$42,928,313$42,203,530.63$11,786$741.30+$42.92M → SAVAW
3$2,545,616,701$2,499,683,405.64$12,944$910.50+$2545.60M → SAVAW
4$141,255,910,403$138,532,100,533.89$14,343$1,127.28+$141255.90M → SAVAW
5$7,335,374,338,812$7,184,230,514,680.15$16,053$1,408.17+$7335374.32M → SAVAW
6$356,516,885,536,661$348,668,034,994,132.70$18,167$1,776.65+$356516885.52M → SAVAW
7$16,218,956,689,966,618$15,837,483,622,442,392.00$20,815$2,266.60+$16218956689.95M → SAVAW
8$690,711,023,145,868,900$673,356,739,487,604,600.00$24,179$2,927.66+$690711023145.84M → SAVAW
9$27,539,067,734,387,980,000$26,800,006,939,621,900,000.00$28,521$3,833.95+$27539067734387.95M → SAVAW
10$1,028,095,347,812,062,000,000$998,628,545,336,266,700,000.00$34,218$5,098.20+$1028095347812062.00M → SAVAW

SAVAW vs O: Complete Analysis 2026

SAVAW — Stock

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

Full SAVAW Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this SAVAW vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAVAW vs SCHDSAVAW vs JEPISAVAW vs KOSAVAW vs MAINSAVAW vs STAGSAVAW vs ADCSAVAW vs NNNSAVAW vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.